260 related articles for article (PubMed ID: 6667763)
1. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte cholesterol and red blood cells deformability in diabetes mellitus.
Cignarelli M; Damato A; Cospite MR; Guastamacchia E; Nardelli GM; Giorgino R
Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1115-8. PubMed ID: 6814468
[TBL] [Abstract][Full Text] [Related]
3. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
4. The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability.
Martínez M; Vayá A; Gil L; Martí R; Dalmau J; Aznar J
Clin Hemorheol Microcirc; 1998 Jul; 18(4):259-63. PubMed ID: 9741666
[TBL] [Abstract][Full Text] [Related]
5. [Compositional alterations of erythrocyte membrane lipid and red cell deformability in diabetes].
Qiu H
Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):21-3. PubMed ID: 1850649
[No Abstract] [Full Text] [Related]
6. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
7. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
Uddin F; Miah AK
Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the plasma lipoprotein spectrum on the cholesterol level in erythrocyte membranes].
Torkhovskaia TI; Khalilov EM; Fortinskaia ES; Kliuchnikova ZhI; Ryzhkova LK
Vopr Med Khim; 1985; 31(4):83-7. PubMed ID: 4049793
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the erythrocyte in liver cirrhosis: role of cholesterol and plasma phospholipids].
Stufano N; Altomare E; Vendemiale G; Lasorsa G; Romano A; Albano O
Boll Soc Ital Biol Sper; 1985 Jan; 61(1):137-43. PubMed ID: 3977992
[TBL] [Abstract][Full Text] [Related]
10. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
[TBL] [Abstract][Full Text] [Related]
11. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
[TBL] [Abstract][Full Text] [Related]
12. Efflux of cholesterol and phospholipids derived from the haemoglobin-lipid adduct in human red blood cells into plasma.
Nikolić M; Stanić D; Baricević I; Jones DR; Nedić O; Niketić V
Clin Biochem; 2007 Mar; 40(5-6):305-9. PubMed ID: 17291471
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.
Garnier M; Attali JR; Valensi P; Delatour-Hanss E; Gaudey F; Koutsouris D
Metabolism; 1990 Aug; 39(8):794-8. PubMed ID: 2377077
[TBL] [Abstract][Full Text] [Related]
14. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
[TBL] [Abstract][Full Text] [Related]
15. Membrane lipids and protein-bound carbohydrates status during the maturation of reticulocytes to erythrocytes in type 2 diabetics.
Sailaja YR; Baskar R; Srinivas Rao CS; Saralakumari D
Clin Chim Acta; 2004 Mar; 341(1-2):185-92. PubMed ID: 14967175
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte insulin receptor characteristics and erythrocyte membrane lipid composition in healthy men.
Pelikánová T; Kohout M; Hilgertová J; Base J; Farská I; Válek J
Physiol Bohemoslov; 1989; 38(5):419-25. PubMed ID: 2533981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
